ericsphotography / iStockphoto.com
The US Court of Appeals for the Federal Circuit has ordered the Patent Trial and Appeal Board (PTAB) to reconsider its assessments in three inter partes reviews (IPRs), in the wake of the US Supreme Court’s SAS Institute v Iancu decision.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
BioDelivery, Aquestive, inter partes review, patent invalidation, post grant proceedings, unpatentability, US Court of Appeals for the Federal Circuit, SAS
